Clark shared the news on Twitter: “I’ve decided to donate
my brain to the Parkinson’s UK Brain Bank. I was so impressed with the research
work being carried out when I visited the facility with [Rory Cellan-Jones]”.
Clark has already raised thousands of pounds for
Parkinson’s UK, become a celebrity ‘Champion’ for the charity, and worked to
challenge stigma surrounding the condition.
He shared a video in which Cellan-Jones, a BBC technology correspondent who also has Parkinson’s, went behind the scenes of the Brain Bank at Imperial College London’s Hammersmith campus, in the UK. Cellan-Jones spoke to Professor Steve Gentleman in the dissection room, who explained that donated brain tissue is vital to research efforts. He concluded the visit by pledging his own brain.
Clark said: “The brain is the most precious thing we have.
It contains our loves, memories and our personality. Giving it to medical
research is the greatest gift I can offer. Imagine if your brain was the one
that unlocked a cure for this devastating neurological condition?”
He also highlighted that scientific research on brains was
“essential” to finding treatments for the condition.
In the UK, National Health Service organ donation is
considered distinct from brain donation – those wishing to pledge their brain
must submit separate forms to brain banks. Imperial College London is home to the
world’s only brain bank for Parkinson’s research and receives around 120
donations each year.
Fans and members of the Parkinson’s community shared their
admiration for Clark on Twitter, and contributed stories of how family members,
or they themselves, had also pledged their brains.
Twitter user Lisa was inspired by Clark and Cellan-Jones:
Twitter user, Kathryn Dainty, said that her parents had also decided to donate their brains:
While Twitter user Katie Hofman expressed appreciation for Clark as a presenter:
Charity Parkinson’s UK voiced its gratitude for Clark’s ongoing support:
Lead image credit: Lawrence Lustig/PDC
The Parkinson’s UK Brain Bank
The Parkinson’s UK Brain Bank is the only brain bank in the world dedicated to Parkinson’s research. Each brain is split into 250 samples which can then be used in scientific projects. This brain tissue contributes to scientists’ understanding of the condition and the development of new treatments. Many neurological conditions, including Parkinson’s, are unique to humans which means it can be difficult to conduct research on animal brains.
The organisation accepts brains from donors with or without Parkinson’s and plans to joint-fund a new digital brain bank, allowing scientists over the world to benefit from these pledged brains.
5 awesome inventions to reduce troublesome Parkinson’s tremors
Specially designed products to stabilise shaking hands
18 hours ago
New biotech to drive forward GDNF treatment for Parkinson’s disease
UK charity Parkinson’s UK is creating a new company, Vivifi Biotech, to develop a treatment with potential to stop or reverse Parkinson’s disease. The experimental therapy surgically distributes GDNF, a protein that is naturally produced by the brain to protect cells, directly into the brain. The charity previously funded a clinical trial to investigate whether boosting GDNF levels could regenerate dying brain cells in people with Parkinson’s. Over the next two years, it will invest up to £800,000 to prepare for a second trial. Arthur Roach, head of research at Parkinson’s UK, said: “While our initial trial didn’t meet its critical endpoint, it did reveal robust evidence indicating that GDNF can possibly reverse Parkinson’s. This is why Parkinson’s UK is committed to continuing research into this potential treatment.” Vivifi Biotech, Roach added, will “bring the right people together to plan a new trial that meets the needs of patients, regulatory…
New wearable medical device for Parkinson’s disease to launch this year
The Imperial College London Innovation Fund, UK, has invested £205,000 to support UK-based tech company Charco Neurotech in its development of a non-invasive medical device for people with Parkinson’s disease. CUE1, a circular device that attaches to the sternum with medical adhesives, uses specialised vibration to help alleviate physical symptoms of Parkinson’s disease. Initial user testing among people with the condition found that the device improved movement by an average of 16%, with testers reporting benefits for walking and fine motor tasks. Lucy Jung, CEO and co-founder of Charco Neurotech, said: “We believe that CUE1 has the potential to significantly improve [Parkinson’s disease] symptoms through its unique controlled vibration technology. We are excited to continue our work on the device and we look forward to the outcome of our proposed clinical trials.” Charco Neurotech will use the Imperial College investment to initiate a clinical trial and fund the device’s manufacture for…
New study brings scientists a “vital step” closer to understanding Parkinson’s disease
A new study from scientists at the University of Cambridge, UK, has brought researchers “a vital step” closer to discovering the origins of Parkinson’s disease. The research, published in the scientific journal ‘Nature Communications’, offered insights on the protein alpha-synuclein, which clumps together in the neurons of people with Parkinson’s. The study focused on how the protein functions in those without the condition and revealed that it sticks to the inner side of the plasma membrane of nerve cells, but not the outer membrane – an insight that could help in the search for a cure. Lead study author, Dr Giuliana Fusco, said: “This study could unlock more information about this debilitating neurodegenerative disorder that can leave people unable to walk and talk. If we want to cure Parkinson’s, first we need to understand the function of alpha-synuclein, a protein present in everyone’s brains.”